Impact Investment Initiative (Triple I)
for Global Health

Co-Chairs

• 

  Mr.Ken Shibusawa

  CEO, Shibusawa & Company, Inc.
  CEO and Founder, &Capital Inc.
  Chairman, Commons Asset Management
  Member of the Council on “The New Form of Capitalism”
  GSG Japan NAB Chair

  

  Mr.Ken Shibusawa

  CEO, Shibusawa & Company, Inc.
  CEO and Founder, &Capital Inc.
  Chairman, Commons Asset Management
  Member of the Council on “The New Form of Capitalism”
  GSG Japan NAB Chair

  Ken Shibusawa founded in 2001, Shibusawa and Company, Inc., and in 2008, Commons Asset Management. In 2021, he joined Brunswick Group as senior advisor.
  He has extensive market experience at JP Morgan, Goldman Sachs, and Moore Capital, a global macro hedge fund, where he was the representative managing director of the Tokyo Office. He is also co-chair of Global South-Africa Committee at Keizai Doyukai (Japan Association of Corporate Executives), advisor to the Office of the President at the University of Tokyo, member of various government panels, including Prime Minister Kishida’s Council on New Capitalism, and a steering group member of UNDP SDG Impact.
  In 2022, he was named as board member of the newly founded International Foundation for Valuing Impact, as special advisor to the ISSB (International Sustainability Standards Boards) chair. In 2023, he founded &Capital, Inc., an impact fund management company for Africa.

• 

  Mr. Steve Davis

  Senior Advisor and Interim Director of the Philanthropic Partnerships Team, Gates Foundation.
  Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow,
  Member of the Council on Foreign Relations

  

  Mr. Steve Davis

  Senior Advisor and Interim Director of the Philanthropic Partnerships Team, Gates Foundation.
  Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow,
  Member of the Council on Foreign Relations

  Steve Davis serves as a Senior Advisor and Interim Director of the Philanthropic Partnerships Team at Gates Foundation, as a Lecturer at the Stanford Graduate School of Business, and as a member of the Council on Foreign Relations. Steve has deep experience, and sits on numerous boards and advisory groups, focused on the intersection of business, innovation, and social impact. He most recently served as Senior Advisor for McKinsey & Company. Before that, he was Executive Strategic Advisor and Interim Director, China Country Office, for the Gates Foundation, co-chair of the World Health Organization's Digital Health Technical Advisory Group, and Distinguished Fellow for the World Economic Forum. Steve is also the former President & CEO of PATH, a leading global health innovation organization; former Director of Social Innovation at McKinsey; former CEO of Corbis, a digital media pioneer; and as an attorney with K&L Gates. With degrees from Princeton University, University of Washington, and Columbia Law School, Steve also is the author of Undercurrents: Channeling Outrage to Spark Practical Activism (Wiley 2020), and speaks and writes frequently on topics related to corporate engagement in social impact, social innovation, and digital health . He lives with his family in Seattle, Washington.

• 

  Dr. Ayoade Alakija

  The board chair of FIND,
  the World Health Organization (WHO) Special Envoy for the Access to COVID-19 Tools (ACT) Accelerator, and co-chairs the Principals Group.

  

  Dr. Ayoade Alakija

  The board chair of FIND,
  the World Health Organization (WHO) Special Envoy for the Access to COVID-19 Tools (ACT) Accelerator, and co-chairs the Principals Group.

  Dr. Ayoade Alakija is a renowned global health leader with expertise in pandemic preparedness and health security and diplomacy. With over two decades in the field, her dedication to equitable access became especially pronounced during COVID-19. As FIND's board chair and the WHO Special Envoy for the ACT-Accelerator, she focuses on creating transformative impacts, particularly for the Global South.

  In her role as Nigeria's Chief Humanitarian Coordinator, she adeptly managed responses to humanitarian crises, and steered the Oslo Humanitarian Conference for Nigeria and the Lake Chad region. As the Chair of the African Vaccine Delivery Alliance, she has been pivotal in championing Africa's voice for access to medical countermeasures.

  Dr. Alakija is a staunch advocate for women's equity, believing in investing in women not just as a gender initiative but as a profitable business decision. Her voice consistently champions justice, echoing both in influential boardrooms and at the grassroots level.